Literature DB >> 12221673

Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature.

Heiwa Kanamori1, Masatsugu Tanaka, Hiroshi Kawaguchi, Satoshi Yamaji, Katsumichi Fujimaki, Naoto Tomita, Shin Fujisawa, Yoshiaki Ishigatsubo.   

Abstract

We describe a case of a 49-year-old man with chronic myelogenous leukemia (CML) whose coincidental psoriasis resolved following allogeneic bone marrow transplantation (BMT). The patient had suffered from psoriasis for 20 years and was treated with corticosteroid ointment. He was diagnosed as having CML in 1998, and his psoriasis deteriorated following interferon therapy. In March 1999, he received a BMT from an HLA-identical sister after undergoing a conditioning regimen involving busulfan, cytosine arabinoside, and cyclophosphamide. Prophylaxis of acute graft-versus-host disease was done using short-term methotrexate and cyclosporin A. His psoriasis improved immediately and disappeared completely on day 70 after BMT. For 2.5 years, his CML remains in remission and he is free of psoriasis without undergoing immunosuppressive therapy. This case suggests the potential benefits of the treatment of immune-mediated diseases with allogeneic BMT. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12221673     DOI: 10.1002/ajh.10169

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  11 in total

1.  Amelioration of severe psoriasis with psoriatic arthritis for 20 years after allogeneic haematopoietic stem cell transplantation.

Authors:  A C Woods; M J Mant
Journal:  Ann Rheum Dis       Date:  2006-05       Impact factor: 19.103

Review 2.  Angiogenesis drives psoriasis pathogenesis.

Authors:  Regina Heidenreich; Martin Röcken; Kamran Ghoreschi
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

3.  Dysregulated expression of inflammation-related genes in psoriatic dermis mesenchymal stem cells.

Authors:  Xuping Niu; Kaiming Zhang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-05-04       Impact factor: 3.848

Review 4.  Stem cell therapy as a potential treatment option for psoriasis.

Authors:  Piyu Parth Naik
Journal:  An Bras Dermatol       Date:  2022-05-27       Impact factor: 2.113

Review 5.  A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses.

Authors:  Kamran Ghoreschi; Ulrich Mrowietz; Martin Röcken
Journal:  J Mol Med (Berl)       Date:  2003-07-18       Impact factor: 4.599

6.  Adult thymus transplantation with allogeneic intra-bone marrow-bone marrow transplantation from same donor induces high thymopoiesis, mild graft-versus-host reaction and strong graft-versus-tumour effects.

Authors:  Takashi Miyake; Naoki Hosaka; Wenhao Cui; Teruhisa Nishida; Takashi Takaki; Muneo Inaba; Yasuo Kamiyama; Susumu Ikehara
Journal:  Immunology       Date:  2008-09-04       Impact factor: 7.397

Review 7.  Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis.

Authors:  Yu Ri Woo; Dae Ho Cho; Hyun Jeong Park
Journal:  Int J Mol Sci       Date:  2017-12-11       Impact factor: 5.923

Review 8.  New allogeneic hematopoietic stem cell transplantation method: hematopoietic stem cell transplantation plus thymus transplantation for intractable diseases.

Authors:  Naoki Hosaka
Journal:  Clin Dev Immunol       Date:  2013-05-12

9.  Cetuximab treatment in a patient with metastatic colorectal cancer and psoriasis.

Authors:  B Neyns; V Meert; F Vandenbroucke
Journal:  Curr Oncol       Date:  2008-08       Impact factor: 3.677

10.  Transmission of psoriasis by allogeneic bone marrow transplantation and blood transfusion.

Authors:  X Li; J Li; L Wang; X Niu; R Hou; R Liu; Z Hao; C Wang; G Yin; K Zhang
Journal:  Blood Cancer J       Date:  2015-03-13       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.